Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel
Authors:
- 21 August 2020
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 59 (12) , 1438-1446
Abstract
High-throughput sequencing technologies are increasingly used in research but limited data are available on the feasibility and value of these when routinely adopted in clinical practice. We analyz...Keywords
Funding Information
- European Society for Medical Oncology
This publication has 28 references indexed in Scilit:
- Identification of major factors associated with failed clinical molecular oncology testing performed by next generation sequencing (NGS)Molecular Oncology, 2015
- The Clinical Trials Transformation Initiative: innovation through collaborationNature Reviews Drug Discovery, 2014
- Ten years of next-generation sequencing technologyTrends in Genetics, 2014
- Feasibility of real time next generation sequencing of cancer genes linked to drug response: Results from a clinical trialInternational Journal of Cancer, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Next-generation genomics: an integrative approachNature Reviews Genetics, 2010
- Next Generation DNA Sequencing and the Future of Genomic MedicineGenes, 2010
- Massively Parallel Sequencing: The Next Big Thing in Genetic MedicineThe American Journal of Human Genetics, 2009
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Genome sequencing in microfabricated high-density picolitre reactorsNature, 2005